Nanomedicine for cancer therapy : from chemotherapeutic to hyperthermia-based therapy /: from chemotherapeutic to hyperthermia-based therapy. (2017)
- Record Type:
- Book
- Title:
- Nanomedicine for cancer therapy : from chemotherapeutic to hyperthermia-based therapy /: from chemotherapeutic to hyperthermia-based therapy. (2017)
- Main Title:
- Nanomedicine for cancer therapy : from chemotherapeutic to hyperthermia-based therapy
- Further Information:
- Note: Piyush Kumar, Rohit Srivastava.
- Authors:
- Kumar, Piyush
Srivastava, Rohit - Contents:
- Preface; Contents; 1 Nanomedicine for Cancer Therapy; Abstract; 1 Introduction; 2 Conventional Therapy for Breast Cancer; 2.1 Limitation of Conventional Therapy; 3 Multiple Drug Resistance (MDR); 3.1 Drug Efflux and Decrease in Drug Uptake; 3.2 Alteration in Drug Target (Topoisomerase II); 3.3 Change in Detoxifying Enzyme Such Glutathione S-Transferase and Cytochrome P450; 3.4 Increase in DNA Repair; 3.5 Inhibition of Apoptosis by Disruption of Cell Signalling; 3.6 Therapy with Multiple Drug Delivery; 3.6.1 A: Combination of Two Drug Molecule. 3.6.2 B: Combination a Biologics and a Drug Molecule3.6.3 C: Drug Delivery Through Carrier or Nanomedicine; 4 Application of Nanoparticles in Cancer; 4.1 Types of Carriers (NPs) and Its Role in Nanomedicine for Cancer Therapy; 4.1.1 Organic Nanoparticle; 4.1.2 Inorganic Nanoparticle; 4.1.3 Metallic Nanoparticle; 4.1.4 Hybrid Nanoparticle; 4.1.5 Upconversion Nanoparticle; 5 Targeting or Delivery of NPs to the Cancer Cells; 5.1 Passive Targeting; 5.2 Active Targeting or Ligand-Mediated Targeting; 6 Role of Nanomedicine in Modern Day Cancer Therapy; 6.1 Gene Therapy. 6.1.1 DNA/SiRNA Based Gene Therapy6.2 Photodynamic Therapy; 6.2.1 Mechanism of Photodynamic Therapy; 6.2.2 Nanoparticle-Based Photodynamic Therapy; 6.3 Drug Resistance and Heat; 6.4 Therapy Based Thermal Ablation and Hyperthermia; 6.4.1 Types of Hyperthermia; 6.4.2 Heating Systems for Hyperthermia; 6.4.3 Electromagnetic Fields and Heating System/Equipment for HyperthermiaPreface; Contents; 1 Nanomedicine for Cancer Therapy; Abstract; 1 Introduction; 2 Conventional Therapy for Breast Cancer; 2.1 Limitation of Conventional Therapy; 3 Multiple Drug Resistance (MDR); 3.1 Drug Efflux and Decrease in Drug Uptake; 3.2 Alteration in Drug Target (Topoisomerase II); 3.3 Change in Detoxifying Enzyme Such Glutathione S-Transferase and Cytochrome P450; 3.4 Increase in DNA Repair; 3.5 Inhibition of Apoptosis by Disruption of Cell Signalling; 3.6 Therapy with Multiple Drug Delivery; 3.6.1 A: Combination of Two Drug Molecule. 3.6.2 B: Combination a Biologics and a Drug Molecule3.6.3 C: Drug Delivery Through Carrier or Nanomedicine; 4 Application of Nanoparticles in Cancer; 4.1 Types of Carriers (NPs) and Its Role in Nanomedicine for Cancer Therapy; 4.1.1 Organic Nanoparticle; 4.1.2 Inorganic Nanoparticle; 4.1.3 Metallic Nanoparticle; 4.1.4 Hybrid Nanoparticle; 4.1.5 Upconversion Nanoparticle; 5 Targeting or Delivery of NPs to the Cancer Cells; 5.1 Passive Targeting; 5.2 Active Targeting or Ligand-Mediated Targeting; 6 Role of Nanomedicine in Modern Day Cancer Therapy; 6.1 Gene Therapy. 6.1.1 DNA/SiRNA Based Gene Therapy6.2 Photodynamic Therapy; 6.2.1 Mechanism of Photodynamic Therapy; 6.2.2 Nanoparticle-Based Photodynamic Therapy; 6.3 Drug Resistance and Heat; 6.4 Therapy Based Thermal Ablation and Hyperthermia; 6.4.1 Types of Hyperthermia; 6.4.2 Heating Systems for Hyperthermia; 6.4.3 Electromagnetic Fields and Heating System/Equipment for Hyperthermia (Table 6); 6.5 Nanoparticles Based Hyperthermia; 6.6 Nanoparticles Based Magnetic Hyperthermia; 6.7 Nano Radiofrequency Hyperthermia: NRFH; 6.8 Photothermal Therapy (PTT) with Nanoparticles Formulation. 6.8.1 Nanoparticles Mediated Photothermal Therapy6.8.2 Metallic Nanoparticles Mediated PTT; 6.8.3 Dye Encapsulated Nanoparticles Based Photothermal Therapy; 6.9 Nano High Intensity Focussed Ultrasound Hyperthermia (NHIFU); 7 Combinatorial Therapy with Hyperthermia; 7.1 Hyperthermia and Radiation; 7.2 Hyperthermia and Drugs; 7.3 Hyperthermia with Photosensitization; 8 Clinical Trials, Success, and Challenges; 9 Conclusion; 10 Challenges; 11 Prospective; References. … (more)
- Publisher Details:
- Cham, Switzerland : Springer
- Publication Date:
- 2017
- Copyright Date:
- 2017
- Extent:
- 1 online resource (77 pages), illustrations (some color), graphs
- Subjects:
- 616.994061
Materials science
Cancer -- Research
Regenerative medicine
Tissue engineering
Biomedical engineering
Nanotechnology
Neoplasms -- therapy
HEALTH & FITNESS -- Diseases -- General
MEDICAL -- Clinical Medicine
MEDICAL -- Diseases
MEDICAL -- Evidence-Based Medicine
MEDICAL -- Internal Medicine
Biomedical engineering
Cancer -- Research
Materials science
Nanotechnology
Regenerative medicine
Tissue engineering
Materials Science
Nanotechnology
Cancer Research
Biomedical Engineering
Regenerative Medicine/Tissue Engineering
Medical -- Oncology
Technology & Engineering -- Engineering (General)
Science -- Life Sciences -- Biology -- Molecular Biology
Oncology
Biomedical engineering
Cellular biology (cytology)
Oncology
Technology & Engineering -- Nanotechnology & MEMS
Nanotechnology
Electronic books
Electronic book - Languages:
- English
- ISBNs:
- 3319458264
9783319458267
9783319458250
3319458256 - Related ISBNs:
- 3319458256
- Notes:
- Note: Includes bibliographical references.
- Access Rights:
- Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
- Access Usage:
- Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD.DS.373282
- Ingest File:
- 02_354.xml